Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia
Objective: The objective of this study is to determine the prevalence of metabolic syndrome among schizophrenia patients receiving antipsychotic monotherapy in Malaysia. Method: A cross-sectional study was conducted at multiple centres between June 2008 and September 2011. Two hundred and five patie...
Main Authors: | Said, M.A., Hatim, A., Habil, M.H., Zafidah, W., Haslina, M.Y., Badiah, Y., Ramli, M.A., Ananjit, S., Sapini, Y., Shah, M., Mahmud, B., Bulgiba, A., Hairi, N.N. |
---|---|
Format: | Article |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/8261/1/Metabolic_syndrome_and_antipsychotic.pdf |
Similar Items
-
Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics
by: Roffeei, S.N., et al.
Published: (2014) -
Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
by: Said, Mas Ayu, et al.
Published: (2012) -
Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia
by: Lee, C., et al.
Published: (2006) -
Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: Preliminary results
by: Said, M.A., et al.
Published: (2010) -
Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
by: Lee, P., et al.
Published: (2008)